[FATE] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
13-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -9.74%
YoY- -47.65%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 0 0 -971 209 290 472 643 -
PBT -6,067 -6,980 -5,739 -6,073 -5,534 -3,548 -4,155 28.79%
Tax 1 0 -1,633 0 88 100 291 -97.74%
NP -6,067 -6,980 -5,739 -6,073 -5,534 -3,548 -4,155 28.79%
Tax Rate - - - - - - - -
Total Cost 6,067 6,980 4,768 6,282 5,824 4,020 4,798 16.98%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 0.00 0.00 591.04 -2,905.74 -1,908.28 -751.69 -646.19 -
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS -0.30 -0.34 -0.29 -0.32 -0.29 -0.40 -0.47 -25.92%
EPS Diluted -0.30 -0.34 -0.28 -0.32 -0.29 -0.40 -0.47 -25.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.